Intravenous Immunoglobulin (IVIG) in Lung Transplantation
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if intravenous immunoglobulin (IVIG) can prevent
bacterial infections in lung transplant patients with low serum levels of immunoglobulin.
Phase:
Phase 2
Details
Lead Sponsor:
Arcasoy, Selim, M.D. Columbia University
Collaborators:
Columbia University Grifols Therapeutics Inc. Grifols Therapeutics LLC